INS and fungal infectious disease: In a cohort of 17,239 patients, lower-doses of corticosteroid (methylprednisolone, ≤240 mg/d vs. >240 mg/d) were not associated with a significant reduction in mortality, but with reduced hospital and ICU length of stay, hospital costs, length of IMV, need for insulin therapy, and fungal infections [21].